LABORATORY CORPORATION OF AMERICA HOLDINGS Laboratory Corporation of America Holdings Share Price
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.4 USD | +0.03% |
|
-1.53% | -12.71% |
| 04-26 | Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255 | MT |
| 04-26 | Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234 | MT |
| Sales 2024 * | 12.8B 1,024B | Sales 2025 * | 13.4B 1,073B | Capitalization | 16.73B 1,339B |
|---|---|---|---|---|---|
| Net income 2024 * | 973M 77.89B | Net income 2025 * | 1.11B 88.7B | EV / Sales 2024 * | 1.68 x |
| Net Debt 2024 * | 4.82B 386B | Net Debt 2025 * | 3.98B 319B | EV / Sales 2025 * | 1.54 x |
| P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
15.2
x | Employees | 67,000 |
| Yield 2024 * |
1.44% | Yield 2025 * |
1.48% | Free-Float | 99.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Laboratory Corporation of America Holdings
More recommendations
More press releases
More news
| 1 day | +0.03% | ||
| 1 week | -1.53% | ||
| Current month | -9.18% | ||
| 1 month | -7.08% | ||
| 3 months | -11.79% | ||
| 6 months | -3.65% | ||
| Current year | -12.71% |
1 week
196.11
210.63
1 month
196.11218.67
Current year
196.11234.09
1 year
195.01243.30
3 years
195.01317.17
5 years
98.02317.17
10 years
95.12317.17
| Managers | Title | Age | Since |
|---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 31/03/13 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 62 | 15/06/14 |
| Compliance Officer | 65 | 31/01/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 15/05/07 |
Adam Schechter
CEO | Chief Executive Officer | 59 | 31/03/13 |
| Director/Board Member | 74 | 27/04/95 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.97% | 2 M€ | +6.77% | ||
| 1.95% | 8 M€ | +2.44% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 198.4 | +0.03% | 931,317 |
| 25/04/24 | 198.4 | -4.61% | 2,098,112 |
| 24/04/24 | 207.9 | -0.01% | 793,528 |
| 23/04/24 | 208 | +2.41% | 925,458 |
| 22/04/24 | 203.1 | +0.79% | 685,960 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotes
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
14/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
198.4
USD
Average target price
239.1
USD
Spread / Average Target
+20.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.71% | 16.73B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- LH Stock
